Pola Orbis Holdings (PORBF) Fair Value & Analysis
Consumer Defensive · US · Market cap $1.7B
Pola Orbis Holdings
PORBF · US
Fair value as of: Jul 18, 2026
From 22 valuation models · updated 23 days ago
Fair value updated Jul 18, 2026, revised from $7.16 to $5.58 (−22.1%) since Jun 24, 2026.
A solid business, but screening 28% overvalued on our models.
What matters now
- A high-quality business (quality 71/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case ($6.97). The favourable scenario is already priced in.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
60‑month range $7.70 – $37.82 · fair‑value band $4.18 – $6.97 · the $7.70 price screens above the $5.58 fair value. Dashed = 300-day average. As of Jul 18, 2026.
Analysis
Pola Orbis Holdings (PORBF) currently trades at $7.70, while our model-based Fair Value estimate is $5.58, implying the stock looks roughly 27.5% overvalued today. The Quality Score stands at 71/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Pola Orbis Holdings generated revenue of $170B at a net margin of 6.3%. Revenue declined 1.2% year over year. It earns a return on equity of 6.7%. The balance sheet holds a net cash position of $58.2B. Fundamentals as of Jul 18, 2026
Our scenario range runs from $4.18 (bear case) to $6.97 (bull case); at $7.70, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 23% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -28%, PORBF screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Growth DCF ($6.27) versus Earnings-Based ($2.21). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 71 · Market factors (momentum, volatility) 40
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Pola Orbis Holdings Inc., through its subsidiaries, develops, manufactures, and sells cosmetics and related products in Japan, Asia, and internationally. It operates through Beauty Care, Real Estate, and Others segments. The company offers beauty and health products under the POLA, ORBIS, Jurlique, THREE, DECENCIA, and FUJIMI brand names.
Full company description
Pola Orbis Holdings Inc., through its subsidiaries, develops, manufactures, and sells cosmetics and related products in Japan, Asia, and internationally. It operates through Beauty Care, Real Estate, and Others segments. The company offers beauty and health products under the POLA, ORBIS, Jurlique, THREE, DECENCIA, and FUJIMI brand names. It is also involved in the leasing of office buildings in urban areas, as well as management and operation of buildings. Pola Orbis Holdings Inc. was founded in 1929 and is headquartered in Tokyo, Japan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Pola Orbis Holdings reported revenue of $170B in FY2025 versus $179B in FY2021, a compound −1.2%/yr. Reported net income was $9.5B in FY2025, compounding −5.2%/yr from FY2021.
PORBF screens 28% overvalued. Compare with The Procter & Gamble Company →
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $146.80 | $108.16 | -26% |
| Unilever PLC ULN | 1,080 MXN | 1,273 MXN | +18% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,144 | ₹1,000 | -53% |
| Essity AB ESSITYA | kr 279.00 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹1,088 | ₹367.64 | -66% |
| Marico Limited MARICO | ₹846.75 | ₹233.05 | -72% |
| APR Co 278470 | 375,000 KRW | 151,222 KRW | -60% |
| Dabur India Limited DABUR | ₹429.45 | ₹181.60 | -58% |
| Kimberly-Clark de México, S. A. B. de C. V., KIMBERA | 38.07 MXN | 50.09 MXN | +32% |
| PT Unilever Indonesia Tbk UNVR | 1,730 IDR | 1,934 IDR | +12% |
Compare Pola Orbis Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Pola Orbis Holdings (PORBF) overvalued or undervalued?
What is the fair value of PORBF?
What is the quality score of PORBF?
What is the revenue of Pola Orbis Holdings (PORBF)?
What is the net profit margin of PORBF?
Does Pola Orbis Holdings pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Pola Orbis Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.